📞 +91- 9891229135✉ starindia.acc@gmail.com
Mon–Sat: 9:00 AM – 6:00 PM
CDSCO Licensing
CDSCO / DCGI — Regulatory Consultants

CDSCO Licensing for Drugs, Devices & Cosmetics

End-to-end CDSCO / DCGI regulatory approvals — handled by specialists from dossier to license.

💊Drug License💄Cosmetic License🔬Medical Devices🏥DCGI Approval✅0% Failure Rate
⚡
30d–6m
Processing Time
🔬
3
Device Classes (B–D)
🆓
Free
Initial Consultation
❌
0%
Failure Rate
CDSCO / DCGI

End-to-End CDSCO Compliance,
Handled for You

Dossier Preparation · Sugam Portal Filing · Query Response · License Issuance

Regulatory approvals for pharmaceutical drugs, cosmetics, and medical devices under CDSCO / DCGI. We manage the complete licensing journey — from product classification to final approval.

Our CDSCO specialists handle technical dossier preparation, Sugam portal filing, query response management, and liaison with the Drug Controller — so you can focus on bringing your products to market.

CDSCO compliance lab
Trusted by Pharma & MedTech Companies

Drug License · Cosmetic License · Medical Devices · DCGI Approval

Quick Info — CDSCO
Governing BodyCDSCO / DCGI
Governing ActDrugs & Cosmetics Act, 1940
Device RulesMedical Devices Rules 2017
Processing Time30 Days – 6 Months
Applicable ToDrugs, Cosmetics & Devices
📞
Call Us
+91-9891229135
✉
Email Us
starindia.acc@gmail.com
CDSCO Services

Which CDSCO Approval Do You Need?

Different products require different CDSCO pathways. Here's what applies to your product.

💊
Pharma

Drug License

Manufacturing or import license for pharmaceutical drugs and formulations under Drugs & Cosmetics Act.

💄
Cosmetics

Cosmetic License

Import or manufacturing license for cosmetic products sold in India under CDSCO regulations.

🔬
Medical

Medical Device Registration

Registration for medical devices including Class A, B, C & D devices under MDR 2017.

📋
Imports

CDSCO Import License

Import license for drugs, cosmetics and medical devices under Form 10 / Form 8 procedures.

🏥
New Drugs

DCGI Approval

Approval from Drug Controller General of India for new drugs, biologicals and clinical trials.

🧪
Research

Clinical Trial Approval

CDSCO approval for conducting clinical trials in India for new drugs and medical devices.

Why It Matters

Importance & Benefits of CDSCO Licensing

CDSCO approval is a legal mandate under the Drugs & Cosmetics Act — not a voluntary exercise. It directly governs market access, customs clearance, and commercial viability of every drug, device, and cosmetic in India.

⚖️

Legal Mandatory Requirement for Market Access

CDSCO approval is mandatory under the Drugs & Cosmetics Act for all drugs, cosmetics, and medical devices sold, imported, or manufactured in India. No product in scope can legally reach the Indian market without valid CDSCO registration or license.

🚫

Avoid Customs Detention & Import Rejection

Customs authorities actively verify CDSCO registration for drug and device imports. Shipments without valid CDSCO documentation are detained, returned at importer cost, or destroyed. CDSCO licensing is a prerequisite for customs clearance of all regulated healthcare products.

🔬

Medical Device Market Entry

India's medical device market is among the fastest growing in Asia. CDSCO registration under MDR 2017 is the mandatory gateway for Class A, B, C, and D devices — from diagnostics and surgical instruments to implants and in-vitro diagnostics.

💊

Pharmaceutical Drug Approvals

All new drugs, generics, biosimilars, and combination products require DCGI approval before they can be manufactured or imported in India. We manage the complete CTD dossier preparation, Sugam portal filing, and DCGI liaison for drug approvals of all categories.

🏛️

Government & Institutional Procurement

Government hospital tenders, CGHS empanelment, and institutional procurement of drugs and medical devices mandatorily require valid CDSCO registration as an eligibility criterion. Enterprise healthcare buyers also require CDSCO proof before vendor onboarding.

🌍

IAA Services for Foreign Manufacturers

Foreign manufacturers must appoint an Indian Authorized Agent (IAA) to apply for CDSCO approvals. We provide full IAA services — acting as your legal representative for dossier filing, query responses, DCGI liaison, and certificate management.

💄

Cosmetic Import Compliance

All cosmetics imported into India require a CDSCO import license. Certain products — hair dyes, sunscreens, anti-dandruff shampoos — are classified as drugs and require drug-level approval. We identify the correct classification and manage the complete licensing process.

🔁

Structured Renewal & Lifecycle Management

CDSCO licenses and registrations have defined validity periods and renewal cycles. Expired licenses result in loss of market access and customs clearance rights. We manage renewal timelines proactively across your entire product portfolio to ensure uninterrupted compliance.

⚠️
Selling Unapproved Drugs or Devices is a Criminal Offence in India

The Drugs & Cosmetics Act prescribes imprisonment of up to 3 years and fines for manufacturing, importing, or selling drugs or devices without valid CDSCO approval. Customs authorities reject shipments of unapproved products at Indian ports. CDSCO enforcement has intensified significantly since 2020, with increasing scrutiny of medical device imports and cosmetics classified as drugs. Non-compliance risks not just regulatory penalties but irreversible reputational damage in the Indian market.

How It Works

Step-by-Step CDSCO Licensing Process

A clear, expert-guided roadmap from product classification to CDSCO license — timeline varies by product category and regulatory pathway.

01
📌

Product Classification & Regulatory Pathway

We classify your product under the appropriate CDSCO regulatory category — drug, cosmetic, or medical device — and identify the correct application type, applicable rules, and CDSCO department handling your approval. This determines whether your application goes to CDSCO Central Licensing Authority, State Licensing Authority, or DCGI directly.

Tip: Misclassification is the most common cause of CDSCO application rejection at the initial review stage. A product submitted under the wrong category results in rejection and delays of 4–8 weeks. Our regulatory team performs a detailed classification review before every application.
02
📑

Technical Dossier Preparation

We prepare your complete regulatory dossier as per CDSCO requirements — in CTD format for drugs, and as per MDR 2017 format for medical devices. This includes clinical/safety data compilation, GMP certificates, stability data, manufacturing process documentation, and all supporting technical evidence required for your product category.

Tip: CDSCO dossier requirements differ significantly by product category, device class, and whether the product is a new drug, approved drug, or generic. Submitting an incomplete or incorrectly formatted dossier is the #1 cause of CDSCO query letters. We build dossiers to specification the first time.
03
📤

Sugam Portal / Physical Application Filing

We file the complete CDSCO application on the Sugam portal (for most drug and device applications) or physically with the appropriate licensing authority for categories not yet on the portal. Application filing includes correct form selection, fee payment, document upload, and verification of all portal entry fields against the dossier.

Tip: The Sugam portal has separate application flows for new drugs, medical devices, cosmetics, and import licenses — each with different form structures and document requirements. Incorrect portal navigation results in filing under the wrong sub-category. Our team handles every portal type with precision.
04
💬

CDSCO Technical Review & Query Response

CDSCO technical reviewers examine the dossier for completeness and scientific adequacy. If additional information or clarification is needed, CDSCO raises formal queries on the Sugam portal or via official communication. Prompt, accurate, and complete query responses are critical — delayed responses directly extend the approval timeline.

Tip: CDSCO queries typically arrive 4–8 weeks after application submission for devices, and 2–6 months for new drugs. We monitor the Sugam portal daily and prepare technically rigorous query responses within 48–72 hours to keep your approval on track.
05
🔎

DCGI Review / Expert Committee (for New Drugs)

New drugs and certain biological products require review by the Subject Expert Committee (SEC) or Technical Expert Committee (TEC) convened by DCGI. We prepare the SEC presentation package, coordinate the pre-submission meeting where available, and manage all DCGI correspondence through this review phase.

Tip: SEC/TEC review is required for new chemical entities, biosimilars, and new drug combinations. The review timeline depends on meeting schedules, which are typically quarterly. Early engagement with the DCGI review process — which we manage — can significantly reduce the overall approval timeline.
06
✅

License Issuance & Renewal Management

CDSCO issues the drug license, device registration certificate, or import license with a unique registration number. We provide the certificate, advise on correct usage in commercial documentation, and manage proactive renewal reminders. Any product specification change — formulation, indication, manufacturing site — may require a variation application, which we handle.

Important: CDSCO registrations are product and manufacturer specific. A change in manufacturing site, formulation, or labelling requires a formal variation or amendment application. We advise on when changes trigger re-filing obligations and manage the variation process proactively.
Sugam Portal
🖥️

Official CDSCO Portal for All Applications

All CDSCO drug, device, and cosmetic applications are filed on the Sugam portal. The portal has separate application flows for new drugs, medical devices (by class), import licenses, and clinical trials — each with distinct document requirements. Our team handles all Sugam portal navigation, form selection, and submission for every product category.

Why Choose Us?
✓
CTD-compliant dossiers prepared by regulatory scientists
✓
Sugam portal experts — correct form, first time
✓
0% application rejection rate
✓
IAA services for all foreign manufacturers
✓
CDSCO query responses within 48–72 hours
✓
Expert committee (SEC/TEC) preparation support
✓
Proactive renewal tracking across product portfolio
documents
What You Need

Documents Required for CDSCO Licensing

Complete and correctly formatted documentation is the most critical factor in a smooth CDSCO approval. Here is what you need to prepare before filing.

📄
Company Registration & KYC

Certificate of Incorporation, GST registration, PAN, and KYC documents for the Indian applicant entity. For foreign manufacturers, the Indian Authorized Agent's registration documents are required.

📑
Product Technical Dossier (CTD Format)

Complete Common Technical Document dossier for drugs — covering quality (Module 3), non-clinical (Module 4), and clinical data (Module 5) as applicable to the drug category and regulatory pathway.

🏭
GMP Certificate / Manufacturing License

Valid GMP certificate issued by the national regulatory authority of the manufacturing country, confirming that the manufacturing facility meets WHO-GMP or equivalent standards.

📜
Certificate of Pharmaceutical Product (CoPP)

CoPP issued by the competent authority of the country of manufacture, confirming the product is authorized for sale in that country — required for all drug import applications.

🔬
Clinical / Safety Data

Clinical trial data, published clinical evidence, or bridging study data as required by CDSCO for new drugs, new drug combinations, and biological products seeking marketing authorization.

📐
Site Master File (SMF)

Comprehensive document describing the manufacturing facility's operations, quality systems, production processes, and regulatory compliance — required for manufacturing site approvals and new drug dossiers.

📊
Stability Data & Shelf Life Documentation

Stability study data demonstrating the product's quality, safety, and efficacy throughout its claimed shelf life under storage conditions relevant to the Indian climate zones.

🔖
Authorized Signatory & IAA Letter

Letter authorizing the Indian Authorized Agent (IAA) or consultant to file the CDSCO application, respond to queries, and receive the license on behalf of the foreign manufacturer.

💡
Pro Tip: Dossier format mismatches are the #1 cause of CDSCO query letters

The product name, composition, manufacturer details, and specifications in the dossier must exactly match what is entered in the Sugam portal application. Even minor discrepancies trigger CDSCO query letters that add 4–8 weeks to the licensing timeline. Our regulatory team cross-checks every document against the portal entry before submission.

Plan Your Approval

Timelines, Costs, Validity & Renewal

Plan your product launch and compliance calendar with a clear picture of what CDSCO licensing involves from start to finish.

Typical Timeline

Phase-wise Duration

PhaseDurationHandled By
Product Classification & Regulatory Pathway1–3 DaysApplicant / Consultant
Technical Dossier Preparation2–6 WeeksApplicant / Consultant
Sugam Portal / Physical Filing2–4 DaysApplicant / Consultant
CDSCO Technical Review & Query Response4–12 WeeksCDSCO / Applicant
SEC / Expert Committee Review (New Drugs)3–6 MonthsDCGI / Expert Committee
License / Registration Certificate Issuance7–14 DaysCDSCO / DCGI
⏱️Total estimated time: 30 days – 6 months (varies significantly by product category, device class, and CDSCO workload)
Cost Breakdown

CDSCO Licensing Fees

CDSCO Government Application Fee₹1,000 – ₹5,00,000+
Dossier Preparation (CTD / MDR format)Variable by product category
GMP Inspection Fee (if applicable)As prescribed by CDSCO
Annual / Renewal License Fee₹2,000 – ₹50,000
Consultant / IAA / Professional FeesVariable (contact us for quote)
💬CDSCO government fees are prescribed under the Drugs & Cosmetics (Amendment) Rules and vary by product category, device class, and application type. Contact us for a transparent all-in quote for your specific product and regulatory pathway.
Validity & Renewal

Key Rules to Know

📅
3 Years
Drug Import License

Import licenses for drugs are typically valid for 3 years and must be renewed before expiry to maintain uninterrupted customs clearance rights.

🔬
5 Years
Medical Device Registration

Medical device registrations under MDR 2017 are valid for 5 years. Renewal requires a fresh application if any technical specification has changed.

💊
Annual Renewal
Drug Manufacturing License

State-level drug manufacturing licenses require annual renewal. Lapsed manufacturing licenses result in immediate halt of production and export activities.

🔖
Each SKU
Per-Product Registration

Each drug formulation, strength, and dosage form requires separate CDSCO registration. Device variants with different intended uses may also require separate registration.

🔄 Renewal & Variation Management

CDSCO renewal and variation filing require careful management. Common challenges our clients face:

!
Tracking expiry dates across multi-product pharmaceutical portfolios
!
Standard updates under MDR 2017 requiring fresh device testing at renewal
!
Formulation changes triggering variation applications rather than renewals
!
Manufacturing site changes requiring fresh CDSCO/DCGI approval
!
Labelling updates for regulatory compliance requiring variation filing
!
Managing multi-SKU renewal filings for drug product families
CDSCO FAQ
Frequently Asked

CDSCO Licensing FAQs

Start Today

Navigate CDSCO with Confidence

Our regulatory experts will guide you through every step of the CDSCO approval process.
Free consultation. Transparent pricing. Error-free dossiers.

📞 +91-9891229135

India's trusted compliance & certification consultancy. 12+ years, 10,000+ clients, 0% failure rate.

+91-9891229135|+91-9540190334✉ starindia.acc@gmail.com
House No. 211, Ground Floor, Pocket 9,
North West New Delhi – 110086

Our Services

→ BIS Certification→ EPR Registration→ WPC-ETA Approval→ TEC / MTCTE→ BEE Registration→ LMPC Registration→ ISO Certification→ CDSCO / Drug License

Quick Links

→ Home→ About Us→ All Services→ Blog→ Careers→ Contact

Stay Updated

Get regulatory updates, QCO notifications & compliance alerts.

Certified & Recognized By

BISEPRWPCTECISODPIIT
© 2026 SIACC — Star India Accreditation. All rights reserved.|Developed by Developers Infotech Pvt Ltd